These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1374582)

  • 1. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)].
    Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K
    Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
    Bergogne-Bérézin E; Muller-Serieys C; Kafé H
    Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lomefloxacin concentrations in bone after a single oral dose.
    On A; Nightingale CH; Quintiliani R; Sweeney KR; Pasternak HS; Maderazo EG
    Am J Med; 1992 Apr; 92(4A):15S-17S. PubMed ID: 1316064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ofloxacin and norfloxacin concentration in prostatic tissues in patients undergoing transurethral resection of the prostate.
    Chen J; Chen RR; Huang HS
    J Formos Med Assoc; 2001 Aug; 100(8):548-52. PubMed ID: 11678006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion of tosufloxacin into prostatic tissue.
    Uchibayashi T; Hisazumi H; Kanayama J; Kumano K
    Chemotherapy; 1992; 38(3):150-4. PubMed ID: 1380905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lomefloxacin in the treatment of chronic prostatitis.
    Scelzi S; Travaglini F; Nerozzi S; Dominici A; Ponchietti R; Novelli A; Rizzo M
    J Chemother; 2001 Feb; 13(1):82-7. PubMed ID: 11233805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraprostatic distribution of lomefloxacin following multiple-dose administration.
    Kovarik JM; de Hond JA; Hoepelman IM; Boon T; Verhoef J
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2398-401. PubMed ID: 2088193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lomefloxacin prophylaxis in visual laser ablation of the prostate.
    Costa FJ
    Urology; 1994 Dec; 44(6):933-6. PubMed ID: 7527170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter comparison of oral lomefloxacin versus parenteral cefotaxime as prophylactic agents in transurethral surgery.
    Klimberg IW; Childs SJ; Madore RJ; Klimberg SR
    Am J Med; 1992 Apr; 92(4A):121S-125S. PubMed ID: 1316061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of oral lomefloxacin in serum and bronchial mucosa.
    Baldwin DR; Honeybourne D; Andrews JM; Ashby JP; Wise R
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1017-9. PubMed ID: 2393260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Grise P; Dhib M; Valtchev B; Fillastre JP
    Urology; 1991 Aug; 38(2):192. PubMed ID: 1877143
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis in transurethral surgery: oral lomefloxacin versus intravenous cefuroxime.
    Martín-Luengo F; Fontana L; Rico JL; Tomás-Ros M; Murcia A; Romero A
    Methods Find Exp Clin Pharmacol; 1993; 15(1):57-9. PubMed ID: 8386794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concentrations of new quinolone agents in serum and prostate tissue].
    Imai K; Suzuki K; Yamanaka H; Makino T; Yazima H; Takezawa Y; Kitaura K; Shiono A; Sato J; Kato N
    Hinyokika Kiyo; 1994 May; 40(5):401-6. PubMed ID: 7517621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of norfloxacin in prostatic tissues following oral administration in patients with benign prostatic hyperplasia.
    Netto NR; Palma PC; Srulzon GB; Cortado PL; Fonseca RC
    Int Urol Nephrol; 1988; 20(1):47-9. PubMed ID: 2452139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
    Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.
    Wagenlehner FM; Lunz JC; Kees F; Wieland W; Naber KG
    J Chemother; 2006 Oct; 18(5):485-9. PubMed ID: 17127224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of lomefloxacin in radicular cyst and oral tissues following single or multiple oral administration.
    Akimoto Y; Mochizuki Y; Uda A; Omata H; Shibutani J; Nishimura H; Komiya M; Kaneko K; Kawana T; Fujii A
    J Nihon Univ Sch Dent; 1993 Dec; 35(4):267-75. PubMed ID: 8158288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
    Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y
    Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.